technetium has been researched along with Neoplasm Metastasis, Unknown Primary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, F; Giesel, FL; Haberkorn, U; Kratochwil, C; Mafomane, MP; Mehndiratta, A; Schemmer, P; Zechmann, CM | 1 |
| Anderson, JR; Goldberg, JA; Kerr, DJ; McArdle, CS; Mckillop, J; Whatelely, AT; Wilmott, N | 1 |
| Brown, ML; Creagan, ET; Frytak, S; Nelp, W; Salk, D | 1 |
3 other study(ies) available for technetium and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Cancer with unknown primary: finding a needle in a hay stack.
Topics: Humans; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Technetium; Tomography, X-Ray Computed | 2012 |
The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs.
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Colonic Neoplasms; Doxorubicin; Drug Carriers; Humans; Infusions, Intra-Arterial; Iodine Radioisotopes; Liver Neoplasms; Microspheres; Middle Aged; Mitomycin; Neoplasms, Unknown Primary; Radionuclide Imaging; Rectal Neoplasms; Regional Blood Flow; Technetium | 1992 |
A technetium-labeled monoclonal antibody for imaging metastatic melanoma.
Topics: Aged; Antibodies, Monoclonal; Bone Neoplasms; Female; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms, Unknown Primary; Skin Neoplasms; Technetium; Tomography, Emission-Computed, Single-Photon | 1991 |